Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Brightgene Bio-medical Technology Co. Ltd.

Headquarters: Suzhou, China
Year Founded: 2001
Status: Public
Industry Sector: HealthTechnology
CEO: Jian Dong Yuan, PhD
Number Of Employees: N/A
Enterprise Value: N/A
PE Ratio: 93.81
Exchange/Ticker 1: Shanghai:688166
Exchange/Ticker 2: N/A
Latest Market Cap: $2,517,630,167

BioCentury | Aug 12, 2019
Finance

Chipscreen sets high standard in Shanghai debut

Chipscreen’s robust debut could entice companies to choose a Shanghai listing over one in Hong Kong
BioCentury | Jul 31, 2019
Financial News

Chipscreen sets pace for biotech IPOs in Shanghai

Shanghai IPO values Chipscreen at $1.2B, opening the door for biopharma listings on the STAR market
Items per page:
1 - 10 of 12